| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 1.5e-05 | 1 |